Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Other Working Capital Changes (2021 - 2025)

Bio Essence has reported Other Working Capital Changes over the past 5 years, most recently at -$131168.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes changed N/A year-over-year to -$131168.0; the TTM value through Dec 2025 reached -$66903.0, down 42.04%, while the annual FY2025 figure was -$66903.0, 42.04% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$131168.0 at Bio Essence, down from $43161.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $91285.0 in Q3 2023 and troughed at -$238401.0 in Q4 2023.
  • A 5-year average of -$16143.5 and a median of $1218.0 in 2021 define the central range for Other Working Capital Changes.
  • On a YoY basis, Other Working Capital Changes climbed as much as 6328.52% in 2023 and fell as far as 1045.4% in 2023.
  • Year by year, Other Working Capital Changes stood at -$5114.0 in 2021, then soared by 593.1% to $25217.0 in 2022, then tumbled by 1045.4% to -$238401.0 in 2023, then soared by 80.24% to -$47100.0 in 2024, then tumbled by 178.49% to -$131168.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for BIOE at -$131168.0 in Q4 2025, $43161.0 in Q3 2025, and -$61952.0 in Q2 2025.